Medtronic unveils new neurovascular innovation incubator program
Excerpt from the Press Release:
Medtronic (NYSE:MDT) revealed its plans for an incubation and acceleration platform for innovation in the neurovascular space.
In a presentation yesterday at DeviceTalks West in Santa Clara, California, the company unveiled its plan to bring innovations to market to address strokes. Daniel Volz, president of Medtronic Neurovascular, and Derek Crittenden, Medtronic’s new technology & strategy program manager, presented the news.
“We’re pleased to share with you today the Medtronic neurovascular Co-Lab platform,” Volz said. “This is a community platform designed to transform ideas and technologies into novel global therapies by providing physicians and entrepreneurs with insight with support, and most importantly, making sure innovation has the chance to touch as many people around the world as possible.”
About Medtronic Co-Lab
Crittenden explained that the industry “positions” break into four categories. It covers “big strategics,” startups serving as “enablers,” incubators and physicians “leaning into innovation and novel insights.”
Click the button below to read the entire Press Release:
Discover What Sets TrialStat Apart From Ordinary EDC Platforms
Click the image or button below to explore our eClinical Suite Platform and discover what sets TrialStat apart from competing EDC platforms.
Request Your Demo Today!
From rapid database build through database lock, we deliver consistent quality on-time and on-budget. Ready to upgrade your eClinical toolkit?